M

Middle East Pharmaceutical Industries Company SJSC
SAU:4016

Watchlist Manager
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Watchlist
Price: 133.4 SAR -0.45% Market Closed
Updated: May 25, 2024
Section:
 

Relative Value

The Relative Value of one Middle East Pharmaceutical Industries Company SJSC stock under the Base Case scenario is hidden SAR. Compared to the current market price of 133.4 SAR, Middle East Pharmaceutical Industries Company SJSC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Middle East Pharmaceutical Industries Company SJSC Relative Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Multiples

7.9
P/S
P/S
Price to Sales
7.9
vs History
60
vs Industry
18
Median 3Y
8.5
Median 5Y
8.5
Industry
2.4
Forward
7
More Details
40.5
P/E
P/E
Price to Earnings
40.5
vs History
60
vs Industry
11
Median 3Y
43.5
Median 5Y
43.5
Industry
22.8
Forward
34.4
More Details
28.8
P/OCF
P/OCF
Price to OCF
28.8
vs History
60
vs Industry
16
Median 3Y
30.9
Median 5Y
30.9
Industry
17
More Details
82.1
P/FCFE
P/FCFE
Price to FCFE
82.1
vs History
60
vs Industry
7
Median 3Y
88
Median 5Y
88
Industry
23.2
More Details
8.7
P/B
P/B
Price to Book Value
8.7
vs History
60
vs Industry
7
Median 3Y
9.3
Median 5Y
9.3
Industry
2.1
More Details
8
EV/S
EV/S
Enterprise Value to Sales
8
vs History
60
vs Industry
16
Median 3Y
8.6
Median 5Y
8.6
Industry
2.6
Forward
7.1
More Details
13.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
13.1
vs History
60
vs Industry
15
Median 3Y
14
Median 5Y
14
Industry
5.1
More Details
30
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
30
vs History
60
vs Industry
11
Median 3Y
32.1
Median 5Y
32.1
Industry
13.5
Forward
24.6
More Details
34.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
34.6
vs History
60
vs Industry
12
Median 3Y
37
Median 5Y
37
Industry
16.9
Forward
28.8
More Details
29.2
EV/OCF
EV/OCF
Enterprise Value to OCF
29.2
vs History
60
vs Industry
16
Median 3Y
31.3
Median 5Y
31.3
Industry
15.8
More Details
43.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
43.9
vs History
60
vs Industry
11
Median 3Y
47
Median 5Y
47
Industry
17.7
More Details
6.7
EV/IC
EV/IC
Enterprise Value to IC
6.7
vs History
60
vs Industry
14
Median 3Y
7.2
Median 5Y
7.2
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Middle East Pharmaceutical Industries Company SJSC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SA
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
2.7B SAR 7.9 40.5 30 34.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
767.4B USD 21.4 125 61.1 69.6
DK
Novo Nordisk A/S
CSE:NOVO B
4.1T DKK 17 46.4 34.6 37.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
353.7B USD 4.1 9.2 11.3 14.8
US
Merck & Co Inc
NYSE:MRK
328B USD 5.3 142.2 35.4 57.8
UK
AstraZeneca PLC
LSE:AZN
190.6B GBP 5.1 38.2 174.8 278.8
CH
Roche Holding AG
SIX:ROG
183.7B CHF 3.1 16 9.1 10.8
CH
Novartis AG
SIX:NOVN
179.5B CHF 3.3 11.2 8.5 12.5
US
Pfizer Inc
NYSE:PFE
163.7B USD 3 -529.7 12.8 20.7

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 140,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.